Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BM-derived MSCs with everolimus in kidney transplant recipients
2013-000819-25Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of everolimus and tacrolimus in kidney transplant (2 arms), sponsored by Leiden University Medical Center. Started Aug 2013; status: active.
02
Drugs
everolimustacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2013-000819-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000819-25.